Abstract
Pseudomonas aeruginosa is recognized as one of the six most important pathogens in terms of antimicrobial resistance («ESKAPE» pathogens), and included by WHO in the group of microorganisms for which the need for development of new antimicrobial agents is crucial. In 2015, P. aeruginosa was the second (after Klebsiella spp.) most common nosocomial bacterial pathogen in Russia with the following resistance rates: amikacin – 45.2%, imipenem – 51.5%, meropenem – 53.3%, colistin – 2.2%, piperacillin/tazobactam – 61.4%, ceftazidime – 56.8%, ciprofloxacin – 61.2%. The majority of carbapenemase-producing isolates in Russia belong to the two epidemic lineages – CC235 and CC654.
Institute of Antimicrobial Chemotherapy, Smolensk State Medical University, Smolensk, Russia
Institute of Antimicrobial Chemotherapy, Smolensk State Medical University, Smolensk, Russia
Institute of Antimicrobial Chemotherapy, Smolensk State Medical University, Smolensk, Russia
Institute of Antimicrobial Chemotherapy, Smolensk State Medical University, Smolensk, Russia
Institute of Antimicrobial Chemotherapy, Smolensk State Medical University, Smolensk, Russia
Institute of Antimicrobial Chemotherapy, Smolensk State Medical University, Smolensk, Russia
-
1.
Rice L.B. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J Infect Dis. 2008;197(8):10791081.
-
2.
Reshedko G.K., Ryabkova E.L., Farashchuk A.N., Stratchounski L.S., and ROSNET study group. Non-Fermenting GramNegative Nosocomial Pathogens in Russian ICUs: Antimicrobial Resistance Problems. Klinicheskaja mikrobiologija i antimikrobnaja himioterapija. 2006;8:243-259. Russian.
-
3.
Reshedko G.K., Ryabkova E.L., Kretchikova O.I., et al. Antimicrobial Resistance Patterns of Gram-negative Nosocomial Pathogens in Russian ICUs. Klinicheskaja mikrobiologija i antimikrobnaja himioterapija. 2008;10:96-112. Russian.
-
4.
Skleenova E., Sukhorukova M., Timokhova A., et al. Sharp increase in carbapenem-non-susceptibility and carbapenemase production rates in nosocomial Gram-negative bacteria in Russia over the last decade. 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 2012, Denver, CO, USA. Abstract C21092.
-
5.
Edelstein M.V., Skleenova E.Yu., Shevchenko O.V., et al. Prevalence and Molecular Epidemiology of Gram-negative Bacteria Producing Metallo-b-lactamases (MBLs) in Russia, Belarus and Kazakhstan. Klinicheskaja mikrobiologija i antimikrobnaja himioterapija. 2012;14:132-152. Russian.
-
6.
Sukhorukova М.V., Edelstein М.V., Skleenova Е.Yu., et al. Antimicrobial Resistance of Nosocomial Pseudomonas aeruginosa Isolates in Russia: Results of National Multicenter Surveillance Study «MARATHON» 2011-2012. Klinicheskaja mikrobiologija i antimikrobnaja himioterapija. 2014;16:273-279. Russian.
-
7.
Magiorakos A.P., Srinivasan A., Carey R.B., et al. Multidrugresistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268-281.
-
8.
Edelstein M.V., Skleenova E.N., Shevchenko O.V., et al. Spread of extensively resistant VIM-2-positive ST235 Pseudomonas aeruginosa in Belarus, Kazakhstan, and Russia: a longitudinal epidemiological and clinical study. Lancet Infect Dis. 2013;13(10):867-876.
-
9.
Oliver A., Mulet X., López-Causapé C., Juan C. The increasing threat of Pseudomonas aeruginosa high-risk clones. Drug Resist Updat. 2015;21-22:41-59.
-
10.
Castanheira M., Deshpande L.M., Costello A., Davies T.A., Jones R.N. Epidemiology and carbapenem resistance mechanisms of carbapenem-non-susceptible Pseudomonas aeruginosa collected during 2009-11 in 14 European and Mediterranean countries. J Antimicrob Chemother. 2014;69(7):1804-1814.
-
11.
Woodford N., Turton J.F., Livermore D.M. Multiresistant Gramnegative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol Rev. 2011;35(5):736-755.
-
12.
Curran B., Jonas D., Grundmann H., Pitt T., Dowson C.G. Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa. J Clin Microbiol. 2004;42(12):5644-5649.
-
13.
Wright L.L., Turton J.F., Livermore D.M., Hopkins K.L., Woodford N. Dominance of international ‘high-risk clones’ among metallo-betalactamase-producing Pseudomonas aeruginosa in the UK. J Antimicrob Chemother. 2015;70(1):103-110.
-
14.
Pasteran F., Faccone D., Gomez S.,et al. Detection of an international multiresistant clone belonging to sequence type 654 involved in the dissemination of KPC-producing Pseudomonas aeruginosa in Argentina. J Antimicrob Chemother. 2012;67(5):1291-1213.
-
15.
Mataseje L.F., Peirano G., Church D.L., et al. Colistin-Nonsusceptible Pseudomonas aeruginosa Sequence Type 654 with blaNDM-1 Arrives in North America. Antimicrob Agents Chemother. 2016;60(3):17941800.
-
16.
Koh T.H., Khoo C.T., Tan T.T., et al. Multilocus sequence types of carbapenem-resistant Pseudomonas aeruginosa in Singapore carrying metallo-beta-lactamase genes, including the novel bla(IMP-26) gene. J Clin Microbiol. 2010;48(7):2563-2564.
-
17.
Samuelsen O., Toleman M.A., Sundsfjord A., et al. Molecular epidemiology of metallo-beta-lactamase-producing Pseudomonas aeruginosa isolates from Norway and Sweden shows import of international clones and local clonal expansion. Antimicrob Agents Chemother. 2010;54(1):346-352.
-
18.
Wright L.L., Turton J.F., Hopkins K.L., Livermore D.M., Woodford N. Genetic environment of metallo-beta-lactamase genes in Pseudomonas aeruginosa isolates from the UK. J Antimicrob Chemother. 2015;70(12):3250-3258.
-
19.
Pobiega M., Maciąg J., Chmielarczyk A., et al. Molecular characterization of carbapenem-resistant Pseudomonas aeruginosa strains isolated from patients with urinary tract infections in Southern Poland. Diagn Microbiol Infect Dis. 2015;83(3):295-297.
-
20.
Global priority list of antibioticresistant bacteria to guide research, discovery, and development of new antibiotics. 2017. Available at: www.who.int/medicines/publications/global-priority-list-antibioticresistant-bacteria/en/.